Role of Iron in Dermatology

Iron is involved in several biological reactions and is essential to almost all forms of life. In contrast, iron is potentially toxic. It may participate in many dermatological disorders, including pigmentation changes, inflammation, porphyrias, infections and cancers. The involvement of iron in these disorders entails a variety of mechanisms, including among others simple deposition processes, activation or inactivation of enzymatic systems, impairment of phagocyte functions and interference with apoptosis. A better understanding of the role of iron might provide novel therapeutic strategies based on iron-chelating and/or anti-oxidant agents.

[1]  G. Andrei,et al.  Iron as a potential cofactor in the pathogenesis of Kaposi's sarcoma , 1999 .

[2]  E. Kay,et al.  Screening of patients with iron overload to identify hemochromatosis and porphyria cutanea tarda. , 1997, Archives of dermatology.

[3]  G. Herbich.  Ultrapulse carbon dioxide laser treatment of an iron oxide flesh-colored tattoo. , 1997, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[4]  E. Abel.  Clinical applications of research on angiogenesis , 1996 .

[5]  D. Bissett,et al.  Synergistic topical photoprotection by a combination of the iron chelator 2-furildioxime and sunscreen. , 1996, Journal of the American Academy of Dermatology.

[6]  M. Beylot-Barry,et al.  Gluteal pigmentation after intramuscular iron injections. , 1996, Dermatology.

[7]  Weinberg Ed.  The role of iron in cancer. , 1996 .

[8]  E. Weinberg,et al.  Altered iron metabolism in HIV infection: mechanisms, possible consequences, and proposals for management. , 1996, Infectious agents and disease.

[9]  E. Weinberg.  The role of iron in cancer. , 1996, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[10]  R. Gallo,et al.  Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone , 1995, Nature.

[11]  B. Graubard,et al.  Moderate elevation of body iron level and increased risk of cancer occurrence and death , 1994, International journal of cancer.

[12]  J. Ziegler.  Endemic Kaposi's sarcoma in Africa and local volcanic soils , 1993, The Lancet.

[13]  F. Flowers,et al.  Extensive cutaneous hyperpigmentation caused by minocycline. , 1993, Journal of the American Academy of Dermatology.

[14]  J. Sánchez,et al.  Granulomatous dermatitis to iron oxide after permanent pigmentation of the eyebrows. , 1993, The Journal of dermatologic surgery and oncology.

[15]  C. Morris,et al.  Skin inflammation: reactive oxygen species and the role of iron. , 1992, The Journal of investigative dermatology.

[16]  G. L. West,et al.  Iron overload in Africa. Interaction between a gene and dietary iron content. , 1992, The New England journal of medicine.

[17]  H. Sussman.  Iron in cancer. , 1992, Pathobiology : journal of immunopathology, molecular and cellular biology.

[18]  J. Goldstein,et al.  Earring-induced localized iron tattoo. , 1991, Journal of the American Academy of Dermatology.

[19]  T. Cheatle.  Venous ulceration and free radicals , 1991, The British journal of dermatology.

[20]  M. Cazzola,et al.  Manipulations of cellular iron metabolism for modulating normal and malignant cell proliferation: achievements and prospects. , 1990, Blood.

[21]  H. J. Williams,et al.  Necrotic bilateral buttocks ulcerations occurring after multiple intramuscular iron dextran injections. , 1988, Archives of dermatology.

[22]  H. Baker,et al.  Erythropoietic protoporphyria exacerbated by oral iron therapy , 1988, The British journal of dermatology.

[23]  D. Weatherall,et al.  Iron and infection. , 1996 .

[24]  C. Zugerman.  Contact dermatitis to yellow iron oxide , 1985, Contact dermatitis.

[25]  P. Reichard,et al.  Ribonucleotide reductase--a radical enzyme. , 1983, Science.

[26]  A. Sober,et al.  Drug- and heavy metal--induced hyperpigmentation. , 1981, Journal of the American Academy of Dermatology.

[27]  H. Z. Lund,et al.  Monsel's solution: a histologic nuisance. , 1980, Journal of the American Academy of Dermatology.

[28]  P. Aisen,et al.  Iron transport and storage proteins. , 1980, Annual review of biochemistry.

[29]  W. Dick,et al.  Intramuscular iron and local oncogenesis. , 1977, British medical journal.

[30]  R. Baer.  Allergic contact sensitization to iron. , 1973, The Journal of allergy and clinical immunology.

[31]  Oettlé Ag.  Geographical and racial differences in the frequency of Kaposi's sarcoma as evidence of environmental or genetic causes. , 1962 .

[32]  A. G. Oettlé.  Geographical and racial differences in the frequency of Kaposi's sarcoma as evidence of environmental or genetic causes. , 1962, Acta - Unio Internationalis Contra Cancrum.

[33]  P. Robert,et al.  Etudes sur la pigmentation , 1953 .

[34]  P. J. Hare,et al.  A CASE OF OCCUPATIONAL IRON PIGMENTATION OF THE SKIN. , 1951, The British journal of dermatology.

[35]  E. Traub,et al.  PERMANENT PIGMENTATION FOLLOWING APPLICATION OF IRON SALTS: FOR THE TREATMENT OF IVY POISONING , 1936 .